Office of Clinical Pharmacology and Biopharmaceutics Review NDA: [removed]SUBMISSION DATE: 29 June 2005 BRAND NAME: Argatroban Injection REVIEWER: Alfredo R. Sancho, Ph.D.

First Page		Document Content
Heparins Argatroban Sulfonamides Chemistry Anticoagulant Clinical pharmacology Thrombocytopenia Pharmacometrics Pharmacology Medicine Guanidines		Office of Clinical Pharmacology and Biopharmaceutics Review NDA: [removed]SUBMISSION DATE: 29 June 2005 BRAND NAME: Argatroban Injection REVIEWER: Alfredo R. Sancho, Ph.D. Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 70,29 KB Share Document on Facebook

	1mm") Clear 4mm") DocID: 1ri24 - View Document
	Anatoxin-a, Cylindrospermopsin, Microcystin & Saxitoxin Report Project: Utah Department of Agriculture and Food Sample Identification Sample Site DocID: 1r4Kv - View Document
	Schweizerische Gesellschaft für Endokrinologie und Diabetologie Société Suisse d’Endocrinologie et de Diabétologie Società Svizzera d’Endocrinologia e Diabetologia Societad Svizra d’Endocrinologia e Diabetolog DocID: 1qXHV - View Document
	Язык интерфейса: Русский ranitidine pharmacy. Ask a question or go to Accident and Emergency at the end of the tranquilizer market in OctoberNow performing at several venues around the net. Wh DocID: 1qc5Y - View Document
	SPECIAL AUTHORIZATION REQUEST DPP-4/SGLT2 INHIBITORS Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 – PRESCRIBER INFORMATION DocID: 1pr3h - View Document